Luan Sun

Changzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification.

Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification.

Journal: Gut
Published: January 07, 2026

NAD(P)H: quinone oxidoreductase 1-mediated oxidative stress resistance and tumor microenvironment remodeling in glioblastoma.

NAD(P)H: quinone oxidoreductase 1-mediated oxidative stress resistance and tumor microenvironment remodeling in glioblastoma.

Journal: Neuro-oncology
Published: June 02, 2025

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression.

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression.

Journal: Cancer biology & therapy
Published: February 22, 2024

Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification.

Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification.

Journal: Journal of biomedical research
Published: November 17, 2023

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH.

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH.

Journal: Journal of translational medicine
Published: December 24, 2022

Improving antibody affinity through in vitro mutagenesis in complementarity determining regions.

Improving antibody affinity through in vitro mutagenesis in complementarity determining regions.

Journal: Journal of biomedical research
Published: May 11, 2022

The enhancer rare germline variation rs548071605 contributes to lung cancer development.

The enhancer rare germline variation rs548071605 contributes to lung cancer development.

Journal: Human mutation
Published: March 25, 2021

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma.

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma.

Journal: Journal for immunotherapy of cancer
Published: March 09, 2021

The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression.

The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression.

Journal: Genome biology
Published: October 27, 2018

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.

Journal: Oncotarget
Published: May 01, 2016

ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.

ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.

Journal: Oncotarget
Published: July 31, 2015

SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes.

SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes.

Journal: PloS one
Published: May 28, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026